CASI Pharmaceuticals, Inc. financial statements
CASI Pharmaceuticals, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 20.71M | 20-F |
| Net income | −USD 48.06M | 20-F |
| Cash and equivalents | USD 5.63M | 20-F |
| Total debt | USD 19.19M | 20-F |
CASI Pharmaceuticals, Inc. financials on 6ix · CASI Pharmaceuticals, Inc. on 6ix